Journal of Leukocyte Biology Myeloid cells, immune suppression, tumor immunology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on August 1, 2007

Published online before print May 10, 2007
This Article
Right arrow Full Text (Reprint (PDF))
Right arrow All Versions of this Article:
jlb.0107071v1
82/2/403    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chelvarajan, L.
Right arrow Articles by Bondada, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chelvarajan, L.
Right arrow Articles by Bondada, S.
© by The Society for Leukocyte Biology
Journal of Leukocyte Biology, doi:10.1189/jlb.0107071


Received for publication January 26, 2007.
Revised March 31, 2007.
Accepted for publication April 12, 2007.


Article

Molecular mechanisms underlying anti-inflammatory phenotype of neonatal splenic macrophages

Lakshman Chelvarajan *{dagger}, Diana Popa *, Yushu Liu {ddagger}, Thomas V. Getchell *{sect}, Arnold J. Stromberg {ddagger}, and Subbarao Bondada *{dagger}@

*Sanders Brown Center on Aging and Departments of {dagger}Microbiology, Immunology & Molecular Genetics, {ddagger}Statistics, and {sect}Physiology, University of Kentucky, Lexington, Kentucky, USA

@ To whom correspondence should be addressed. E-mail: bondada{at}uky.edu.


   Abstract

Neonatal humans and rodents are susceptible to infection with encapsulated bacteria as a result of an inability to make antibodies to capsular polysaccharides. This is partly a result of decreased production of proinflammatory cytokines by splenic macrophages (M{Phi}) from neonates. In this study, we show that when stimulated with a variety of agonists to TLR2, -4, and -9, neonatal M{Phi} make less proinflammatory cytokines and more IL-10 than adult M{Phi}. IL-10 appears to have a role in the decreased proinflammatory cytokine production, as neonatal M{Phi} treated with anti-IL-10 receptor antibody or from IL-10-/- mice produced levels of proinflammatory cytokines at a level comparable with that produced by adult M{Phi}. A microarray analysis of RNA from resting and LPS-stimulated M{Phi} from neonatal and adult mice showed that expression of a large number of genes encoding cytokines, chemokines, and their receptors was decreased dramatically in the neonatal M{Phi}, although some cytokines, including IL-10 and IL-16, were enhanced. Several genes in the TLR signaling pathway leading to NF-{kappa}B activation were down-regulated, which may account for the decreased chemokine and cytokine synthesis. It is surprising that p38{alpha} MAPK, known to be required for TLR-induced cytokine secretion, was enhanced in the neonatal M{Phi}. Our studies with the p38 MAPK inhibitor SB203580 suggested that excess p38 MAPK activity can be inhibitory for TLR2-, -4-, and -9-induced production of proinflammatory cytokines but not IL-10. The anti-inflammatory phenotype of the neonatal M{phi} may be unique to the developing organism, although it compromises the neonate’s ability to respond to encapsulated bacteria.

Key Words: TLR • LPS • CpG • cytokines • p38 MAPK • microarray







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2007 by the Society for Leukocyte Biology.